Myelodysplastic syndromes in Thailand: a retrospective pathologic and clinical analysis of 117 cases

作者: Tanin Intragumtornchai , Wichai Prayoonwiwat , Daratana Swasdikul , Nipha Suwanwela , Boonsom Chaimongkol

DOI: 10.1016/S0145-2126(98)00022-8

关键词:

摘要: To gain more insight into the understanding of myelodysplastic syndromes (MDS) as they occur in Thailand, a retrospective clinicopathologic analysis was conducted patients (age > 15 years) diagnosed MDS from January 1992 to December 1996 at five major medical centers various geographic regions country. The central reviewers independently examined bone marrow and peripheral blood smears all classify disease according French-British-American (FAB) classification. There were total 117 eligible patients. median age 56 years (range 16-86). male:female ratio 1:1. Thirty-two percent younger than 40 years. frequency FAB subtypes RA/RARS, 54.7; RAEB, 23.1; CMML, 9.4; RAEB-T, 12.8%. Anemia most common symptom presenting 84.6% In 34 whom cytogenetics analysed, 44.1% revealed abnormalities. Of these, monosomy 7 trisomy 8 aberration, each being detected 26.7% Transfusions main therapeutic modality 80% Kaplan-Meier 5 year survival rate 29% for whole group with 24 months. Twenty-five had progressed acute myelogenous leukemia (AML) time disease-progression 23 CMML RAEB-T 58.4, 19.9, 10.7 8.7 months, respectively (P < 0.001). stepwise Cox regression percentage blasts only parameter significantly associated progression. On comparison data other countries, Thai is considerably lower western population but comparable asian countries. distribution are similar. prognostic features, however, lie rather degree observed cytopenia.

参考文章(25)
T.J.M. de Witte, H. Löffler, W. Gassman, N. Schmitz, Intensive chemotherapy and bone marrow transplantation for myelodysplastic syndromes Seminars in Hematology. ,vol. 33, pp. 196- 205 ,(1996)
Ohyashiki K, Kuramoto A, Hotta T, Hirai H, Abe T, Asano S, Toyama K, Hirashima K, Kuriya S, Yoshida Y, Clinical implications of chromosomal abnormalities in 401 patients with myelodysplastic syndromes: a multicentric study in Japan. Leukemia. ,vol. 7, pp. 499- 508 ,(1993)
Sante Tura, Michele Baccarani, Eliana Zuffa, Domenico Russo, Renato Fanin, Alfonso Zaccaria, Mauro Fiacchini, None, Interferon alfa-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia. The New England Journal of Medicine. ,vol. 330, pp. 820- 825 ,(1994) , 10.1056/NEJM199403243301204
David R. Cox, Regression Models and Life-Tables Springer Series in Statistics. ,vol. 34, pp. 527- 541 ,(1992) , 10.1007/978-1-4612-4380-9_37
Hwei-Fang Tien, Chiu-Hwa Wang, Sou-Ming Chuang, Jyh-Ming Chow, Fen-Yu Lee, Ming-Chi Liu, Yao-Chang Chen, Ming-Ching Shen, Dong-Tsam Lin, Kai-Hsin Lin, Cytogenetic studies, ras mutation, and clinical characteristics in primary myelodysplastic syndrome Cancer Genetics and Cytogenetics. ,vol. 74, pp. 40- 49 ,(1994) , 10.1016/0165-4608(94)90027-2
P. Greenberg, R. Negrin, A. Neubauer, E. Liu, N. Ginzton, Mutations in the ras proto-oncogenes in patients with myelodysplastic syndromes. Leukemia. ,vol. 8, pp. 638- 641 ,(1994)
Andrew W. Maksymiuk, Jeffrey S. Bratvold, Wendolyn Ezzat, Leonard K. T. Tan, Leo F. Skinnider, Non‐hodgkin's lymphoma in Saskatchewan. A review of 10 years' experience Cancer. ,vol. 73, pp. 711- 719 ,(1994) , 10.1002/1097-0142(19940201)73:3<711::AID-CNCR2820730335>3.0.CO;2-4
Jean-Etienne Goasguen, Richard Garand, Marie Bizet, Jean-Louis Bremond, Jacques Gardais, Marie Pierre Callat, Françoise Accard, Jacques Chaperon, Prognostic factors of myelodysplastic syndromes--a simplified 3-D scoring system. Leukemia Research. ,vol. 14, pp. 255- 262 ,(1990) , 10.1016/0145-2126(90)90133-T
E. L. Kaplan, Paul Meier, Nonparametric Estimation from Incomplete Observations Springer Series in Statistics. ,vol. 53, pp. 319- 337 ,(1992) , 10.1007/978-1-4612-4380-9_25